You have read all your free articles, to continue reading subscribe to read the rest of this content.
Jonas Jendi is an Investment Manager within the life science sector at Industrifonden, an evergreen venture capital fund, based in Stockholm, focusing on early-stage companies within life science and technology. In the current life science portfolio he is responsible for Nuevolution, Smartfish and AAlready a subscriber Login You have read…
Nordic Life Science asked Nikolaj Sørensen, CEO of Orexo, about his opinion on the ongoing U.S. drug pricing debate. Sørensen said that historically U.S. drug pricing has been recognized to be much more attractive than European drug pricing. And this is still the truth for pharmaceuticals withAlready a subscriber Login You…
Elias Zerhouni, President of Sanofi R&D, was recently awarded 'Executive of the Year' at the 13th Annual Scrip Awards in London. Dr. Zerhouni was recognized for displaying exemplary leadership in his field by a panel of senior healthcare experts from across the world. He was commended for hisAlready a subscriber…
Gesynta Pharma has successfully raised SEK 190 million in one of the largest private biotech placements of the year in the Nordics. The placement was led by European life science fund manager Hadean Ventures, joined by existing investor Industrifonden and private funds. “We believe mPGES-1 iAlready a subscriber Login You…
